Structural analysis of HIV-1 maturation using cryo-electron tomography

PLoS Pathog. 2010 Nov 24;6(11):e1001215. doi: 10.1371/journal.ppat.1001215.

Abstract

HIV-1 buds form infected cells in an immature, non-infectious form. Maturation into an infectious virion requires proteolytic cleavage of the Gag polyprotein at five positions, leading to a dramatic change in virus morphology. Immature virions contain an incomplete spherical shell where Gag is arranged with the N-terminal MA domain adjacent to the membrane, the CA domain adopting a hexameric lattice below the membrane, and beneath this, the NC domain and viral RNA forming a disordered layer. After maturation, NC and RNA are condensed within the particle surrounded by a conical CA core. Little is known about the sequence of structural changes that take place during maturation, however. Here we have used cryo-electron tomography and subtomogram averaging to resolve the structure of the Gag lattice in a panel of viruses containing point mutations abolishing cleavage at individual or multiple Gag cleavage sites. These studies describe the structural intermediates correlating with the ordered processing events that occur during the HIV-1 maturation process. After the first cleavage between SP1 and NC, the condensed NC-RNA may retain a link to the remaining Gag lattice. Initiation of disassembly of the immature Gag lattice requires cleavage to occur on both sides of CA-SP1, while assembly of the mature core also requires cleavage of SP1 from CA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Electron Microscope Tomography
  • HIV Infections / metabolism
  • HIV Infections / virology
  • HIV-1 / physiology*
  • HIV-1 / ultrastructure*
  • Humans
  • Models, Molecular
  • Point Mutation / genetics
  • Protein Structure, Tertiary
  • RNA, Viral / genetics
  • RNA, Viral / metabolism*
  • Tomography / methods
  • Virion / physiology
  • Virion / ultrastructure*
  • gag Gene Products, Human Immunodeficiency Virus / chemistry*
  • gag Gene Products, Human Immunodeficiency Virus / genetics
  • gag Gene Products, Human Immunodeficiency Virus / metabolism*

Substances

  • RNA, Viral
  • gag Gene Products, Human Immunodeficiency Virus